These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17853940)

  • 1. Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent.
    Zhang B; Maris CH; Foell J; Whitmire J; Niu L; Song J; Kwon BS; Vella AT; Ahmed R; Jacob J; Mittler RS
    J Clin Invest; 2007 Oct; 117(10):3029-41. PubMed ID: 17853940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells and Stat3 are essential for CD137-induced CD8 T cell activation-induced cell death.
    Zhang B; Zhang Y; Niu L; Vella AT; Mittler RS
    J Immunol; 2010 May; 184(9):4770-8. PubMed ID: 20351189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CD137 antibodies in the treatment of autoimmune disease and cancer.
    Mittler RS; Foell J; McCausland M; Strahotin S; Niu L; Bapat A; Hewes LB
    Immunol Res; 2004; 29(1-3):197-208. PubMed ID: 15181282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonistic anti-CD40 antibody profoundly suppresses the immune response to infection with lymphocytic choriomeningitis virus.
    Bartholdy C; Kauffmann SØ; Christensen JP; Thomsen AR
    J Immunol; 2007 Feb; 178(3):1662-70. PubMed ID: 17237416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses.
    Tan JT; Whitmire JK; Ahmed R; Pearson TC; Larsen CP
    J Immunol; 1999 Nov; 163(9):4859-68. PubMed ID: 10528187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
    Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of CD4+ cells in sustaining lymphocyte proliferation during lymphocytic choriomeningitis virus infection.
    Kasaian MT; Leite-Morris KA; Biron CA
    J Immunol; 1991 Mar; 146(6):1955-63. PubMed ID: 1672337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins.
    Kyburz D; Speiser DE; Battegay M; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1993 Jul; 23(7):1540-5. PubMed ID: 8325330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression.
    Fung-Leung WP; Kündig TM; Zinkernagel RM; Mak TW
    J Exp Med; 1991 Dec; 174(6):1425-9. PubMed ID: 1683893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral CD4 and CD8 T-cell memory: differences in the size of the response and activation requirements.
    Whitmire JK; Murali-Krishna K; Altman J; Ahmed R
    Philos Trans R Soc Lond B Biol Sci; 2000 Mar; 355(1395):373-9. PubMed ID: 10794058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment.
    Gangaplara A; Martens C; Dahlstrom E; Metidji A; Gokhale AS; Glass DD; Lopez-Ocasio M; Baur R; Kanakabandi K; Porcella SF; Shevach EM
    PLoS Pathog; 2018 Apr; 14(4):e1006985. PubMed ID: 29672594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses.
    Halstead ES; Mueller YM; Altman JD; Katsikis PD
    Nat Immunol; 2002 Jun; 3(6):536-41. PubMed ID: 12021777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of IL-12 on the response and susceptibility to experimental viral infections.
    Orange JS; Wolf SF; Biron CA
    J Immunol; 1994 Feb; 152(3):1253-64. PubMed ID: 7905500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-10 plays an early role in generating virus-specific T cell anergy.
    Maris CH; Chappell CP; Jacob J
    BMC Immunol; 2007 Jun; 8():8. PubMed ID: 17570849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocytic choriomeningitis virus infection yields overlapping CD4+ and CD8+ T-cell responses.
    Dow C; Oseroff C; Peters B; Nance-Sotelo C; Sidney J; Buchmeier M; Sette A; Mothé BR
    J Virol; 2008 Dec; 82(23):11734-41. PubMed ID: 18829752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus.
    Arribillaga L; Sarobe P; Arina A; Gorraiz M; Borrás-Cuesta F; Ruiz J; Prieto J; Chen L; Melero I; Lasarte JJ
    Vaccine; 2005 May; 23(27):3493-9. PubMed ID: 15855007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD134 Costimulation Couples the CD137 Pathway to Induce Production of Supereffector CD8 T Cells That Become IL-7 Dependent.
    Lee SJ; Rossi RJ; Lee SK; Croft M; Kwon BS; Mittler RS; Vella AT
    J Immunol; 2007 Aug; 179(4):2203-14. PubMed ID: 17675480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-GITR agonist therapy intrinsically enhances CD8 T cell responses to chronic lymphocytic choriomeningitis virus (LCMV), thereby circumventing LCMV-induced downregulation of costimulatory GITR ligand on APC.
    Clouthier DL; Zhou AC; Watts TH
    J Immunol; 2014 Nov; 193(10):5033-43. PubMed ID: 25281716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses.
    Taraban VY; Rowley TF; O'Brien L; Chan HT; Haswell LE; Green MH; Tutt AL; Glennie MJ; Al-Shamkhani A
    Eur J Immunol; 2002 Dec; 32(12):3617-27. PubMed ID: 12516549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model.
    Morales-Kastresana A; Sanmamed MF; Rodriguez I; Palazon A; Martinez-Forero I; Labiano S; Hervas-Stubbs S; Sangro B; Ochoa C; Rouzaut A; Azpilikueta A; Bolaños E; Jure-Kunkel M; Gütgemann I; Melero I
    Clin Cancer Res; 2013 Nov; 19(22):6151-62. PubMed ID: 24030703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.